Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | ARSJ |
| Upstream (Parents) |
|---|
| (<<) ADORA2B → ARSJ |
| (<<) BCL2L1 → ARSJ |
| (<<) CALB1 → ARSJ |
| (<<) DNM1L → ARSJ |
| (<<) DNM3 → ARSJ |
| (<<) E2F4 → ARSJ |
| (<<) EGR1 → ARSJ |
| (<<) EIF6 → ARSJ |
| (<<) ELK3 → ARSJ |
| (<<) EMP1 → ARSJ |
| (<<) FERMT1 → ARSJ |
| (<<) FGF7 → ARSJ |
| (<<) FHIT → ARSJ |
| (<<) FKSG2 → ARSJ |
| (<<) FZD2 → ARSJ |
| (<<) GNB2 → ARSJ |
| (<<) GNB2L1 → ARSJ |
| (<<) HRAS → ARSJ |
| (<<) HSPA8 → ARSJ |
| (<<) HSPA9 → ARSJ |
| (<<) ITGAE → ARSJ |
| (<<) ITGAV → ARSJ |
| (<<) MMP15 → ARSJ |
| (<<) MMP3 → ARSJ |
| (<<) MT1G → ARSJ |
| (<<) MYL3 → ARSJ |
| (<<) NFKB1 → ARSJ |
| (<<) OSBPL8 → ARSJ |
| (<<) PALM → ARSJ |
| (<<) PDE2A → ARSJ |
| (<<) PRKCD → ARSJ |
| (<<) RAB15 → ARSJ |
| (<<) RAD51L3 → ARSJ |
| (<<) RASA1 → ARSJ |
| (<<) RBP1 → ARSJ |
| (<<) RNF11 → ARSJ |
| (<<) SIGLEC15 → ARSJ |
| (<<) SLC6A14 → ARSJ |
| (<<) ST3GAL1 → ARSJ |
| (<<) SULF1 → ARSJ |
| (<<) SYNJ2 → ARSJ |
| (<<) TCOF1 → ARSJ |
| (<<) TIMP1 → ARSJ |
| (<<) UGDH → ARSJ |
| (<<) VPS28 → ARSJ |
| (<<) ZBED2 → ARSJ |
| Downstream (Children) |
|---|
| ARSJ → DLX2 (>>) |
| ARSJ → EREG (>>) |
| ARSJ → EVX1 (>>) |
| ARSJ → GAD1 (>>) |
| ARSJ → MYH14 (>>) |
| ARSJ → UST (>>) |
| ARSJ → WNT4 (>>) |
